GED Capital has completed the exit of Vitro Group by transferring the Spanish producer of reagents for diagnostics to single asset continuation vehicle.
Buyer adds cosmetic surgery chain to portfolio of healthcare assets; is targeting IPO on Nordic Growth markets
Flexible remit allows EUR 2bn vehicle to invest through macroeconomic uncertainty
Fund-of-funds has made two investments to date and plans to attract further European institutional LPs
Acquisition of the Swedish customer and employee feedback platform follows a Houlihan Lokey-led sale process